{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262946378358528.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1509852"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1509852"}}],"dc:title":[{"@value":"Adalimumab in Patients with Active Noninfectious Uveitis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262946378358401","@type":"Researcher","foaf:name":[{"@value":"Glenn J. Jaffe"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358539","@type":"Researcher","foaf:name":[{"@value":"Andrew D. Dick"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358529","@type":"Researcher","foaf:name":[{"@value":"Antoine P. Brézin"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358537","@type":"Researcher","foaf:name":[{"@value":"Quan Dong Nguyen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358538","@type":"Researcher","foaf:name":[{"@value":"Jennifer E. Thorne"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358535","@type":"Researcher","foaf:name":[{"@value":"Philippe Kestelyn"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358533","@type":"Researcher","foaf:name":[{"@value":"Talin Barisani-Asenbauer"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358400","@type":"Researcher","foaf:name":[{"@value":"Pablo Franco"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358541","@type":"Researcher","foaf:name":[{"@value":"Arnd Heiligenhaus"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358528","@type":"Researcher","foaf:name":[{"@value":"David Scales"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358532","@type":"Researcher","foaf:name":[{"@value":"David S. Chu"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358536","@type":"Researcher","foaf:name":[{"@value":"Anne Camez"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358534","@type":"Researcher","foaf:name":[{"@value":"Nisha V. Kwatra"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358540","@type":"Researcher","foaf:name":[{"@value":"Alexandra P. Song"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358542","@type":"Researcher","foaf:name":[{"@value":"Martina Kron"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358531","@type":"Researcher","foaf:name":[{"@value":"Samir Tari"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946378358530","@type":"Researcher","foaf:name":[{"@value":"Eric B. Suhler"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2016-09-08","prism:volume":"375","prism:number":"10","prism:startingPage":"932","prism:endingPage":"943"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1509852"}],"createdAt":"2016-09-07","modifiedAt":"2016-11-02","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050012570391734912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1050018218946284160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1050294045367931392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Outcomes of Microhook ab Interno Trabeculotomy in Consecutive 36 Eyes with Uveitic Glaucoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1050587981429258752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Adalimumab in Active and Inactive, Non-Infectious Uveitis : Global Results from the VISUAL I and VISUAL II Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013276264546688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431111765120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708440787328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Noninfectious uveitis in the Asia–Pacific region"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643782914688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864777484416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Humira in Ocular Inflammations Taper (HOT) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360571339728020864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt–Koyanagi–Harada disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092492794496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The effectiveness of adalimumab treatment for non-infectious uveitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092561402752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572532413365504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118765515648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118805754752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232186221312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641034474496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567729898496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567797667072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814757217024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus"}]},{"@id":"https://cir.nii.ac.jp/crid/1362539019300456832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti‑inflammatory effects of the NF‑κB inhibitor dehydroxymethylepoxyquinomicin on ARPE‑19 cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1362541648441375872","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Uveitis: contrasting the approaches in Japan and the United States"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680299904640","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"サルコイドーシスによるぶどう膜炎に対するアダリムマブ治療"},{"@language":"en","@value":"Adalimumab in sarcoidosis patients with refractory non-infectious uveitis"},{"@language":"ja-Kana","@value":"サルコイドーシス ニ ヨル ブドウマクエン ニ タイスル アダリムマブ チリョウ"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1509852"},{"@type":"CROSSREF","@value":"10.1007/s40123-022-00493-z_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1016/j.addr.2023.114870_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1136/bjo-2024-326239_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1038/s41433-018-0223-z_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.2147/oarrr.s328211_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1016/j.ajo.2023.09.012_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1080/09273948.2018.1491605_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00878-w_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1080/25785826.2019.1642080_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.3389/fmicb.2020.522579_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00897-7_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1136/bjophthalmol-2020-317354_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.3390/ijms23010341_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1080/09273948.2022.2092007_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.3390/jcm11133768_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1016/j.ophtha.2017.12.039_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.7878/jjsogd.37.1_2_25_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1016/j.ophtha.2020.10.036_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2021.640473_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1007/s00417-020-05032-9_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.4103/sjopt.sjopt_204_22_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.3892/mmr.2020.11115_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"},{"@type":"CROSSREF","@value":"10.1007/s10384-018-0633-2_references_DOI_PQMH5UkJUsXWrC2Q4sg7DwN0JvL"}]}